ArticleJournal for immunotherapy of cancer2014

Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study.

Uwe Trefzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.